Correlation Between Mersana Therapeutics and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Mersana Therapeutics and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mersana Therapeutics and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mersana Therapeutics and Inozyme Pharma, you can compare the effects of market volatilities on Mersana Therapeutics and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mersana Therapeutics with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mersana Therapeutics and Inozyme Pharma.
Diversification Opportunities for Mersana Therapeutics and Inozyme Pharma
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mersana and Inozyme is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Mersana Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mersana Therapeutics are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Mersana Therapeutics i.e., Mersana Therapeutics and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Mersana Therapeutics and Inozyme Pharma
Given the investment horizon of 90 days Mersana Therapeutics is expected to generate 2.2 times more return on investment than Inozyme Pharma. However, Mersana Therapeutics is 2.2 times more volatile than Inozyme Pharma. It trades about 0.03 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.7 per unit of risk. If you would invest 204.00 in Mersana Therapeutics on August 28, 2024 and sell it today you would lose (4.00) from holding Mersana Therapeutics or give up 1.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mersana Therapeutics vs. Inozyme Pharma
Performance |
| Timeline |
| Mersana Therapeutics |
| Inozyme Pharma |
Mersana Therapeutics and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mersana Therapeutics and Inozyme Pharma
The main advantage of trading using opposite Mersana Therapeutics and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mersana Therapeutics position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |